Japan Tissue Engineering Co., Ltd.

Japan Tissue Engineering Co., Ltd. operates a regenerative medicine business in Japan through three segments: Regenerative Medicine Product, Regenerative Medicine Contract, and Research and Development Support. It supplies autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for medical treatment, and also provides tissue-engineered medical products. In addition, the company researches and develops human three-dimensional cultured tissue models for cosmetics and external drug development, as well as for research using skin and cornea tissues, and offers regenerative medicine contract development and manufacturing services. Founded in 1999 and headquartered in Gamagori, Japan, it operates as a subsidiary of Teijin Limited.